Introduction
============

Putrescine (PUT), a linear diamine, is produced by plants from agmatine or ornithine. Agmatine route, which originated in plants by the horizontal gene transfer from the cyanobacterial ancestor of the chloroplast ([@B39]), involves three enzymes: arginine decarboxylase (ADC), agmatine iminohydrolase (AIH), and N-carbamoylputrescine amidohydrolase (CPA). The first enzyme of the pathway, pyridoxal 5′-phosphate-dependent ADC, converts arginine to agmatine. Later, agmatine is hydrolyzed to N-carbamoylputrescine by AIH, a dimeric enzyme with a 5-bladed propeller fold ([@B50]). The last step of the pathway that provides PUT involves the action of an octameric CPA with a characteristic subunit arrangement that resembles an incomplete helix ([@B52]). The alternative route for PUT biosynthesis, ornithine pathway, is carried out by ornithine decarboxylase (ODC). However, this enzyme is not common for all plant species and some plants lack ODC relying only on agmatine biotransformation ([@B21]).

Longer polyamines are produced by aminopropyltransferases (APTs), enzymes that catalyze the transfer of an aminopropyl group from decarboxylated S-adenosylmethionine (dc-SAM), a universal cofactor of APTs, to a polyamine substrate. In plant organisms, different polyamines are produced by distinct specialized APTs ([@B53]). Thus, spermidine synthase (SPDS) utilizes PUT as the substrate for spermidine (SPD) biosynthesis. Spermine and thermospermine are produced from SPD by spermine synthase (SPMS) and thermospermine synthase (TSPS), respectively. Although both APTs use the same substrate they present significant differences that predestine them to produce distinct products ([@B49]). From the group of plant APTs, only the structures of TSPS from *Medicago truncatula* (*Mt*TSPS, PDB ID 6bq2) ([@B49]), and SPDS1 from *Arabidopsis thaliana* (*At*SPDS1, PDB ID 1xj5, Center for Eukaryotic Structural Genomics) are known, however there is no published structural characterization of *At*SPDS1.

Polyamines are abundant cationic compounds that play a critical role in the growth and development of plants ([@B57]). Increased stress tolerance of plants is one of the most important roles assigned to polyamines ([@B7]). They take part in the regulation of stress signaling pathways ([@B31]), scavenging of the reactive oxygen species ([@B48]; [@B30]; [@B42]) and stabilization of the photosynthetic apparatus ([@B26]). Levels of the polyamines undergo massive changes in plants upon the biotic stress ([@B28]) and their exogenous application may increase the resistance to pathogen infection ([@B19]). Moreover, polyamines modulate the rate of membrane transport ([@B46]; [@B47]), as well as they interact with nucleic acids and proteins, thus they take part in the regulation of the transcription and translation ([@B18]; [@B27]; [@B57]). Dysfunctions of the polyamine biosynthesis pathway cause growth retardation, sterility, and other pathologies ([@B22]). Polyamines are used to create conjugates with hydroxycinnamic acids to form hydroxycinnamic acid amides, essential compounds for certain developmental processes ([@B57]) and precursors of defensive compounds ([@B9]). SPD plays an essential role in the hypusination process. It acts as a donor of the aminobutyl moiety for the posttranslational modification of lysine residue of the translation factor eIF5A. eIF5A participates in translation elongation and in plants is important for the control of flowering time, the aerial and root architecture, root hair growth, and adaptation for challenging growth conditions ([@B5]).

Spermidine synthases most likely originated from the common ancestor before the separation of prokaryotes and eukaryotes. Then, independently in plants, fungi, and animals, they probably duplicated and evolved to acquire SPMS activity ([@B40]). Another enzyme that probably originated from SPDS is PUT *N-*methyltransferase ([@B23]). Interestingly, the dc-SAM binding motifs of plant SPDSs are more homologous to this enzyme than to mammalian or bacterial SPDSs ([@B24]). On the other hand, TSPS originated in plants from the horizontal gene transfer, similarly to the proteins from the agmatine route. Therefore, it is not surprising that TSPSs show clear divergence from other APTs of the flowering plants ([@B49]), while SPDS and SPMS are more similar. *A. thaliana*, similarly to many other dicots, has two gene paralogs encoding SPDS1 and SPDS2 whose distribution differs across tissues, stage of development and environment ([@B1]). SPDS1, SPDS2, and SPMS in *A. thaliana* present dual subcellular localization and are localized in the nucleus and cytosol ([@B6]). They can interact with each other to form heteromultimers ([@B44]), however, these are found only in the nucleus. SPDSs can be potently inhibited by CHA and its cyclic or aromatic derivatives ([@B54]). The application of CHA leads to accumulation of the free polyamines and may stimulate radicle emergence and the miotic index ([@B16]).

In this work, we present a structural comparison of the two SPDS isoforms from *A. thaliana* (*At*SPDS1 and *At*SPDS2). We also discuss the binding mode of dc-SAM, the inhibition of *At*SPDS by CHA and the structural rearrangements of *At*SPDS upon the ligand binding.

Materials and Methods {#s1}
=====================

Cloning, Overexpression, and Purification of *At*SPDS1 and *At*SPDS2
--------------------------------------------------------------------

Complementary DNA (cDNA) of *A. thaliana* was obtained according to the protocol described earlier ([@B51]). The cDNA was used as a template for a polymerase chain reaction in order to isolate *At*SPDS1 and *At*SPDS2 open reading frames (ORF), which are annotated in the GenBank as AJ251296.1 and AJ251297.1, respectively. Two sets of forward primers were designed in a way to clone complete ORFs and the truncated ORFs. Complete ORF of *At*SPDS1 was isolated with the following primers: TACTTCCAATCCAATGCCATGGACGCTAAAGAAACCTCT GCCA (forward) and TTATCCACTTCCAATGTTATCAATTGG CTTTTGACTCAATGACCTTCTT (reverse). In case of *At*SPDS2 these were: TACTTCCAATCCAATGCCATGTCTTCA ACACAAGAAGCGTCTGTTA (forward) and TTATCCA CTTCCAATGTTACTAGTTGGCTTTCGAATCAATCACCTTC (reverse). The second variant of *At*SPDS1 was isolated with the use of the same reverse primer and a different forward primer (TACTTCCAATCCAATGCCAAAAAGGAACCTGCTTGTTTC TCCACTG) which allowed to clone the gene starting from codon 34. Forward primer for the isolation of the second *At*SPDS2 variant starting from the codon 39 was as follows: TACTTCCAATCCAATGCCAAGGAGCCTTCTTGTATGTCCT CTATTATT. The amplification products were incorporated into a pMCSG68 vector (Midwest Center for Structural Genomics) according to the ligase-independent cloning protocol ([@B32]). Then, BL21 Gold *Escherichia coli* competent cells (Agilent Technologies) were transformed with the vectors which carried *At*SPDS1 and *At*SPDS2 genes and the truncated constructs. The proteins were overexpressed with N-terminal His~6~-tag followed by the tobacco etch virus (TEV) protease cleavage site and Ser-Asn-Ala linker, which is not cleaved from the expressed proteins. The cells were cultured at 37°C in LB medium with ampicillin at 150 μg/ml concentration until OD~600~ reached value 0.9 and then the culture was cooled to 10°C for 1 h. The culture was induced with 0.5 mM of isopropyl-β-D-thiogalactopyranoside, and the overexpression was carried out at 18°C for the next 16 h. Afterward, the cells were cooled to 4°C and were pelleted by centrifugation at 3,500*g* for 20 min. The supernatant was discarded and 35 ml of the binding buffer \[50 mM HEPES pH 7.4; 500 mM NaCl; 20 mM imidazole; 1 mM tris(2-carboxyethyl)phosphine, TCEP\] was added to the cell pellets in order to resuspend them before freezing at -80°C. The cells were then thawed and subjected to sonication in an ice/water bath. The total time of sonication was 4 min and it consisted of 4-s sonication bursts with the intervals of 26 s. Then, after centrifugation at 25,000*g* for 30 min at 4°C, the supernatant was separated from the cell debris by decantation and applied on the column packed with 5 ml of HisTrap HP resin (GE Healthcare) which was connected to Vac-Man (Promega). The resin with captured proteins was washed five times with 40 ml of the binding buffer. *At*SPDS1 and *At*SPDS2, still carrying the His~6~-tags, were eluted with 20 ml of elution buffer (50 mM HEPES pH 7.4, 500 mM NaCl, 400 mM imidazole, 1 mM TCEP). Then, the portion of His~6~-tagged TEV protease (final concentration of 0.1 mg/ml) was added to the protein samples. The cleavage of the His~6~-tags from *At*SPDS1 and *At*SPDS2 was carried out in parallel to the overnight dialysis at 4°C against the buffer containing: 50 mM HEPES pH 8.0, 500 mM NaCl, 1 mM TCEP. Then, the samples were applied on the HisTrap HP resin in order to remove cleaved His~6~-tag and His~6~-tagged TEV protease. *At*SPDS1 and *At*SPDS2 were then concentrated with Amicon concentrators (Millipore) and applied on the HiLoad Superdex 200 16/60 column (GE Healthcare) connected to the AKTA FPLC system (Amersham Biosciences). Size-exclusion chromatography buffer contained 50 mM HEPES pH 7.4, 100 mM KCl, 50 mM NaCl, 1 mM TCEP.

Crystallization and Data Collection
-----------------------------------

Crystallization trials were carried out parallelly for two constructs (full-length and truncated) of both *At*SPDS isoforms by the sitting drop method. Crystallization conditions of the full-length apo *At*SPDS1 were as follows: 16 mg/ml protein concentration, 0.2 M ammonium sulfate, 0.1 M BIS-TRIS at pH 5.5, 25% polyethylene glycol (PEG) 3350. Crystals were cryoprotected before diffraction experiment by 25% glycerol. Truncated apo *At*SPDS2 crystallized from 19 mg/ml in 76th conditions of the MORPHEUS screen ([@B20]). There was no necessity to use any cryoprotectant before freezing *At*SPDS2 crystals. The complex of *At*SPDS1 with dc-SAM and CHA was obtained by mixing truncated *At*SPDS1 at 23 mg/ml with ligands (10 mM final concentration of each ligand). Crystals were obtained by streak seeding in conditions containing 0.18 M ammonium sulfate, 0.09 M BIS-TRIS at pH 5.5, and 22% PEG 3350. 25% MPD was used as a cryoprotectant. For clarity, the complex of *At*SPDS1 with dc-SAM and CHA is further referred to as *At*SPDS1-CHA. The concentration of protein samples was determined spectrophotometrically at 280 nm using theoretical molar extinction coefficients calculated in *ProtParam* ([@B17]).

The diffraction data were collected at the SER-CAT 22-BM beamline at the Advanced Photon Source (APS), Argonne National Laboratory, United States. The diffraction data were processed with *XDS* ([@B29]). Since the diffraction of all crystals demonstrated significant anisotropy, scaling of the data was performed with *STARANISO*^[1](#fn01){ref-type="fn"}^. The anisotropic cut-off surface for *At*SPDS1 data has been determined from 1.80 Å (best diffraction limits) to 3.14 Å (worst diffraction limits). In the case of *At*SPDS2, the anisotropic diffraction limits were between 2.0 and 2.77 Å. For the *At*SPDS1-CHA complex, the diffraction limits were between 1.80 and 2.70 Å. [Table 1](#T1){ref-type="table"} provides detailed statistics for spherical and anisotropic truncation. After anisotropic truncation of the data, the electron density maps of all refined structures were significantly improved. Coordinates and structure factors were deposited in the PDB under the accession numbers 6o63 (*At*SPDS1), 6o64 (*At*SPDS2), and 6o65 (*At*SPDS1-CHA).

###### 

Data collection and refinement statistics.

  ---------------------------------------------------------------------------------------------
  Structure                      *At*SPDS1           *At*SPDS2            *At*SPDS1-CHA
  ------------------------------ ------------------- -------------------- ---------------------
  **Data collection**                                                     

  Beamline                       22-BM               22-BM                22-BM

  Wavelength (Å)                 1.00                1.00                 1.00

  Temperature (K)                100                 100                  100

  Oscillation range (°)          0.25                0.25                 0.25

  Space group                    *P*2~1~             *P*2~1~              *P*2~1~

  Unit cell parameters (Å,°)     89.5, 76.3, 90.2\   75.6, 162.7, 97.5\   89.2, 107.6, 142.4\
                                 β = 104.7           β = 100.2            β = 95.3

  Resolution^1^ (Å)              44.6--1.8^1a^\      46.0--2.0^1b^\       47.6--1.8^1c^\
                                 (1.86--1.8)         (2.07--2.0)          (1.85--1.8)

  Reflections collected/unique   396350/95958\       534541/125268\       667473/200872\
                                 (19131/4794)        (26656/6263)         (34955/10041)

  Completeness (%)                                                        

     Spherical                   87.9 (45.6)         80.2 (42.8)          80.6 (44.0)

     Ellipsoidal                 95.4 (78.5)         97.1 (97.1)          93.4 (95.5)

  Multiplicity                   4.1 (4.0)           4.3 (4.3)            3.3 (3.5)

  *R*~merge~ (%)                 5.5 (54.7)          5.6 (55.7)           8.9 (41.3)

  \<*I*/σ(*I)*\>                 14.1 (2.5)          16.5 (2.5)           8.2 (2.7)

  *CC~1/2~* (%)                  99.9 (78.7)         99.9 (84.4)          99.7 (83.3)

  **Refinement**                                                          

  *R~free~* reflections          1083                1234                 1621

  No. of atoms (non-H)                                                    

     Protein                     8875                17520                18075

     Ligands                     62                  134                  290

     Solvent                     986                 936                  2103

  *R*~work~/*R*~free~ (%)        16.5/22.2           17.6/23.1            21.9/26.1

  Mean ADP^2^ (Å^2^)             25                  35                   18

  RMSD^3^ from ideal geometry                                             

     Bond lengths (Å)            0.013               0.014                0.016

     Bond angles (^o^)           1.80                1.86                 1.98

  Ramachandran statistics (%)                                             

     Favored                     97                  95                   96

     Allowed                     3                   5                    4

     Outliers                    0                   0                    0

  PDB code                       6o63                6o64                 6o65

                                                                          
  ---------------------------------------------------------------------------------------------

1

Best anisotropic diffraction limit cut-off.

1a

Worst diffraction limit after cut-off is 3.14 Å.

1b

Worst diffraction limit after cut-off is 2.77 Å.

1c

Worst diffraction limit after cut-off is 2.70 Å.

2

ADP, atomic displacement parameter (B factor).

3

RMSD, root-mean-square deviation. Values in parentheses refer to the highest resolution shell.

Structure Determination and Refinement
--------------------------------------

The previously deposited structure *At*SPDS1 (PDB ID: 1xj5, Center for Eukaryotic Structural Genomics, unpublished structure) was used as an initial model for the phase determination of our *At*SPDS1 structure. The model was then taken for the subsequent steps of manual and automatic refinement with *Coot* ([@B13]) and *Refmac* ([@B43]). *TLS* parameters ([@B59]) were applied at the later stages of the structure refinement. In the case of *At*SPDS2 and *At*SPDS1-CHA structures, the coordinates of the dimer from the refined structure of *At*SPDS1 were used as a search model in *Phaser* ([@B38]). The refinement was analogical to that of *At*SPDS1. *R*~work~, *R*~free~ factors ([@B8]) and geometric parameters were controlled during refinement. The quality of refined structures was investigated in *PROCHECK* ([@B35]) and *MolProbity* ([@B10]). The final refinement statistics are given in [Table 1](#T1){ref-type="table"}. Geometrical restraints for CHA were generated in *eLBOW* ([@B41]).

Small-Angle X-Ray Scattering Measurement
----------------------------------------

SAXS data were collected from the samples of the full-length *At*SPDS1 and the truncated construct of *At*SPDS2 at 7 and 4.5 mg/ml, respectively. The experiments were carried out at the BioCAT 18-ID beamline ([@B14]) at APS. The sample was applied to the WTC-015S5 column (Wyatt Technologies) coupled to the Infinity II HPLC (Agilent Technologies) system on the in-line size exclusion chromatography (SEC-SAXS) setup. After the column, the sample was analyzed with the Agilent UV detector, a Multi-Angle Light Scattering (MALS) detector and a Dynamic Light Scattering (DLS) detector (DAWN Helios II, Wyatt Technologies), and an RI detector (Optilab T-rEX, Wyatt). Then, it was sent to the SAXS flow cell, a 1.5 mm quartz capillary. The scattering intensity was collected with the exposure 0.5 and 2-s intervals at 1.03 Å wavelength at room temperature on a Pilatus3 1M detector (Dectris). The sample-to-detector distance was 3.5 m and the collected q-range was 0.004--0.4 Å^-1^. *BioXTAS* *RAW* 1.5.1 ([@B25]) was used for data reduction and analysis. To increase the signal-to-noise ratio several frames from to the elution peak of the chromatogram were averaged. The subtraction of the buffer signal from the sample scattering was done on the averaged frames directly proximal the sample peak. The *Rg* value calculated from the Guinier and distance distribution analysis were 29.4 and 29.6 Å for *At*SPDS1 and *At*SPDS2, respectively. The calculated maximum dimensions of the particles (*D*~max~) for *At*SPDS1 and *At*SPDS2 were 100 and 103 Å. The further calculation was performed with the *qRg* limits for 0.28--1.30 for *At*SPDS1 and 0.26--1.30 for *At*SPDS2. *DAMMIF* ([@B15]), *DAMAVER* ([@B58]), *DAMMIN* ([@B56]), and *DAMFILT* were consecutively used for the calculation of the *ab initio* envelopes, averaging, refinement and filtration. Twofold symmetry restraints were used for the envelope calculations. SAXS envelopes were superposed with the crystallographic dimers in *SUPCOMB*.

Other Software Used
-------------------

Molecular illustrations were made in UCSF *Chimera* ([@B45]). The sequence conservation scores were determined with *ConSurf* ([@B3]). The electrostatic potentials were calculated in *PDB2PQR* and *APBS* ([@B4]; [@B11]). Polder omit maps were calculated in *Phenix* ([@B36]).

Results and Discussion
======================

*At*SPDS1 and *At*SPDS2 Structures
----------------------------------

The structures of apo *At*SPDS1 and *At*SPDS2 present the PEG molecules (absorbed from the crystallization solution) bound within the active site ([Figure 1A,B](#F1){ref-type="fig"}). The conformation of this linear ligand mimics PUT, providing the information about the substrate binding mode inside the catalytic pocket. The third determined structure is the crystal complex of *At*SPDS1 with two bound compounds, dc-SAM and CHA ([Figure 1C](#F1){ref-type="fig"}), which precisely shows the binding mode of the cofactor and the inhibitor of SPDS.

![*At*SPDS structure. **(A)** PEG molecule bound in the chain B of *At*SPDS1 structure, **(B**) PEG molecule bound in the chain G of *At*SPDS2 structure, and **(C)** dc-SAM and CHA bound in the chain A of *At*SPDS1-CHA structure; green mesh represents omit maps (contoured at 4σ) calculated in *Phenix* ([@B36]). **(D)** Superposition of *At*SPDS1-CHA (chain A, green) and *At*SPDS2 (chain G, yellow) with the schematic depiction of the active site (dc-SAM is shown in black and CHA, which depicts the location of the polyamine groove, is shown in pink). **(E)** Sequence alignment of *At*SPDS2 (top) and *At*SPDS1 (bottom); residues are color-coded by the conservation score based on the results from *ConSurf* ([@B3]); the alignment of the flowering plant SPDS sequences derived from the phylogenetic analysis described in [@B49] was used in the calculations; the secondary structure elements are shown above the alignment: helices (green cylinders), sheets (violet arrows), and coil regions (yellow lines); regions that were disordered in the structures are marked with dotted lines; the provided sequence positions refer to the *At*SPDS2 sequence.](fpls-10-00555-g001){#F1}

*At*SPDS1 and *At*SPDS2 share the fold of polyamine biosynthesis proteins with the characteristic two-domain topology ([Figure 1D](#F1){ref-type="fig"}). The N-terminal domain is smaller (about 100 residues). It is built of six β-strands that fold into two β-sheets, the two-stranded β-hairpin and the four-stranded antiparallel β-sheet. Additional β strand (Ser46-Ile48) is formed only in chain H of *At*SPDS2 (one of the eight chains in the asymmetric unit) creating three-stranded β-sheet at the N-terminus. In other chains of *At*SPDS2 structure and all chains of *At*SPDS1, the N-terminus is either more disordered or curved in a way that no additional β-strand is formed. The C-terminal domain has a Rossmann fold--like topology with a core β-sheet built of seven strands (five parallel and two antiparallel strands) that is buried between two helical bundles. The active site of *At*SPDS is formed between the N-terminal and C-terminal domains ([Figure 1D](#F1){ref-type="fig"}).

The overall conformation of *At*SPDS1 and *At*SPDS2, and the distribution of the secondary structure elements are almost identical in these two isoforms ([Figure 1D](#F1){ref-type="fig"}). Single chains of *At*SPDS1 and *At*SPDS2 superposed to each other present about 0.5 Å root-mean-square deviation. Also, the overall sequence conservation of plant SPDSs ([Figure 1E](#F1){ref-type="fig"}) is high with many conserved regions that determine common characteristics of SPDSs in the plant kingdom. Only three regions show significantly lower conservation, and these are the N-terminus (about 45 residues), the region around the disordered loop between β13 and α10, and the C-terminal part ([Figure 1E](#F1){ref-type="fig"}).

*At*SPDS1 and *At*SPDS2 share 83% sequence identity, however, when the highly variable and very flexible N-terminal part (up to Met45 of *At*SPDS2) is excluded from the alignment, the sequence identity is almost 90%. *At*SPDS1 is six-residues shorter than *At*SPDS2 and for the clarity of further analysis, all sequence positions that are identical in both *At*SPDSs are denoted with double numbering, e.g., Asp201/205 indicates aspartic acid in position 201 in *At*SPDS1 and 205 in *At*SPDS2. Four sequence gaps of *At*SPDS1 are in the disordered N-terminus. Two of the missing residues are placed in the long loop, which connects β13 and α10 ([Figure 1E](#F1){ref-type="fig"}). Recently solved structure of another plant APT, TSPS from *M*. *truncatula* (*Mt*TSPS) ([@B49]), shows higher order in this region, which in *Mt*TSPS clearly folds into an additional helix.

Biological Assembly of *At*SPDS1 and *At*SPDS2
----------------------------------------------

Both *A. thaliana* SPDS isoforms are dimers in solution. The estimated molecular weight of the full-length *At*SPDS1 calculated from the SAXS results ([Figure 2A](#F2){ref-type="fig"}) is 74.5 kDa, which almost ideally matches the theoretical dimer mass (73 kDa). In the case of the truncated construct of *At*SPDS2, the SAXS results ([Figure 2B](#F2){ref-type="fig"}) also matched the weight of the dimer (67.8 kDa in comparison to the theoretical value of 66.8 kDa). Also, the calculated *ab initio* envelope of *At*SPDS1 clearly corresponds to the *At*SPDS1 dimer in the crystal lattice ([Figure 2C](#F2){ref-type="fig"}). The SAXS data of *At*SPDS2 presented significantly lower signal-to-noise ratio and the calculated *At*SPDS2 envelope (not shown) was worse in comparison to the envelope of *At*SPDS1, although it resembled the *At*SPDS2 crystallographic dimer in terms of its size. Slightly worse SAXS results for *At*SPDS2 can be explained by a lower concentration of the protein sample used for the analysis.

![SAXS results. SAXS data for **(A)** *At*SPDS1 and **(B)** *At*SPDS2; charts present: the experimental SAXS curve (left), the Guinier plot of the scattering curve with the best fit shown as a black line (center), and the pair-distance distribution function for SAXS data (right). **(C)** *Ab* *initio* averaged SAXS envelope of *At*SPDS1 (violet mesh) superposed with the crystallographic *At*SPDS1 dimer (chains A and B shown in dark green and light green, respectively).](fpls-10-00555-g002){#F2}

All crystal structures are solved in the monoclinic system with *P*2~1~ space group but in different crystal forms ([Table 1](#T1){ref-type="table"}). The asymmetric unit of apo *At*SPDS1 contains two dimers (A-B and C-D), while the complex of *At*SPDS1-CHA and the apo *At*SPDS2 both present four dimers (A-B, C-D, E-F, and G-H) in the asymmetric unit. The dimers of all structures are very similar. The dimer interface of *At*SPDS1 and *At*SPDS2 involves about 50 surface residues, that is about 15% of the subunit surface. It is created by the interactions of both domains ([Figure 2C](#F2){ref-type="fig"}). In the case of the N-terminal domain, residues from the strand β2 and the loops connecting β4-β5 and β6-α1 have a major contribution to the dimer formation. In the C-terminal domains, interface residues are from the loop β11-α8, strand β12, and the two helices, α10 and α11. In the apo *At*SPDS1 crystal structure, dimers A-B and C-D (symmetry-related dimer) form an additional extensive buried surface between N-terminal domains of subunits A and C. This covers about 8% of the subunit surface and involves 12 hydrogen bonds which is recognized through PISA server ([@B34]) as the interface important for oligomerization. No similar tight interdimeric interactions are observed in the other presented structures. Additionally, the SAXS results showing dimers of both *At*SPDS isoforms suggest that these additional interactions are rather the consequence of tight crystal packing of *At*SPDS1. On the other hand, it has been shown that plant APTs may form multiprotein complexes *in vivo* ([@B44]) and the above mentioned interface may be involved in their formation. This somewhat similar tight interaction is actually responsible for the formation of *Mt*TSPS tetramer in the crystal and in solution ([@B49]), where the N-terminal β-hairpins form eight-stranded β-barrel.

Most of the characterized APTs are dimers, analogously to *At*SPDS1 and *At*SPDS2. These include, e.g., *E. coli* SPDS (*Ec*SPDS, PDB ID: 3o4f) ([@B61]) or human SPDS (*Hs*SPDS, PDB ID: 2o05) ([@B60]). The exceptions are the tetrameric SPDSs, like *Thermotoga maritima* SPDS (*Tm*SPDS, PDB ID: 1inl) ([@B33]), *Bacillus subtilis* SPDS (*Bs*SPDS, PDB ID: 1iy9), or *Helicobacter pylori* SPDS (*Hp*SPDS, PDB ID: 2cmg) ([@B37]). In some conditions, the latter protein can form either dimers or tetramers ([@B37]). The biological assembly of the tetrameric SPDSs more resembles the tetramer of *Mt*TSPS with the β-barrel formed by the N-terminal β-hairpins of the four subdomains ([@B49]) rather than the formation between two dimers observed in the apo crystal structure of *At*SPDS1.

The Active Site of *At*SPDS
---------------------------

The large catalytic cavity on the interface between the N-terminal and C-terminal domains is the region of *At*SPDS with the highest negative charge. This feature can be easily explained by the necessity of *At*SPDS to attract dc-SAM and PUT, both presenting the cationic character. The active site is composed of two main compartments, the dc-SAM binding site and the polyamine binding grove. Cofactor binding site is placed closer to the C-terminal domain, while the substrate site is rather buried in the N-terminal domain.

The dc-SAM binding site stretches alongside the glycine-rich region between β7 and α2 (residues Gly128/132-Gly133/137). Its boundaries are marked by Asp182/186 from one side and Gln107/111 from the other side ([Figure 3A](#F3){ref-type="fig"}). Glu151/155, which is responsible for the H-bonding interactions with ribosyl moiety of dc-SAM, virtually divides the dc-SAM binding site into two compartments that accommodate adenosine and aminopropyl moieties, respectively ([Figure 3A](#F3){ref-type="fig"}). The bulky compartment which facilitates adenosine moiety of the cofactor is covered by the very flexible region that comprises η6 together with the flanking loops (see below). The adenosine moiety of the dc-SAM is stacked between Leu212/216 and Ile152/156 and it forms three hydrogen bonds with the surrounding residues ([Figure 3A](#F3){ref-type="fig"}). Two of these H-bonds are created by the N^6^ amine with the carbonyl oxygen atom of Pro208/212 and the OD1 oxygen atom of Asp182/186. The third hydrogen bond is created between the N^1^ of dc-SAM and the backbone amide of Gly183/187. The aminopropyl binding site is significantly smaller. The niche is formed by polar residues, Asp131/135, Asp201/205, and Gln107/111 that create three hydrogen bonds with terminal amine of the cofactor's aminopropyl moiety ([Figure 3A](#F3){ref-type="fig"}). Asp201/205 is placed in a way to reach and to deprotonate the amine group of PUT before the reaction. Deprotonated PUT can perform the nucleophilic attack on the carbon atom of the dc-SAM aminopropyl moiety. A very similar hydrogen bonds network between dc-SAM and surrounding residues are present in other SPDSs, like human *Hs*SPDS (PDB ID: 2o0l) ([@B60]). Also, the analogical residues that correspond to Ile152/156 and Leu212/216 are responsible for the stacking of the adenine base of dc-SAM. Plant SPMSs present almost identical highly conserved primary structure of the dc-SAM binding site as *At*SPDS. On the other hand, *Mt*TSPS (PDB ID 6bq2) ([@B49]) shows some differences inside the cofactor binding site. The first difference is the residue that corresponds to Glu151/155 of *At*SPDS and binds the ribose moiety of dc-SAM. In *Mt*TSPS, and in other plant TSPSs, it is Asp129. The other difference concerns Gln107/111, which in *Mt*TSPS is replaced with His. Also, the adenine base is differently stabilized by the apolar residues. The residue corresponding to Leu212/216 is the same, but the difference concerns the interactions from the other side of the plane of the adenine base. In *Mt*TSPS the function of Leu212/216 takes Leu179, the residue in a position corresponding to Ser202/206 of *At*SPDS.

![The active site of *At*SPDS. **(A)** The binding mode of dc-SAM (black) and CHA (pink) shown in the chain A of *At*SPDS1-CHA structure (green); dashed lines indicate hydrogen bonds; residues are numbered accordingly to the sequence positions of *At*SPDS1 and *At*SPDS2, respectively. **(B)** Comparison of the binding mode of CHA (pink) in chain A of *At*SPDS1 structure (green) with PEG molecule (cyan) bound in chain G of *At*SPDS2 structure (yellow).](fpls-10-00555-g003){#F3}

The polyamine binding site is an elongated tunnel-shaped cavity that stretches deep down the N-terminal domain, from Asp201/205 to Trp55/59. Trp55/59, which is a part of the N-terminal β-hairpin, limits the length of the cavity and shapes its bottom wall. The key residues in this part of the active site are easily recognized in the structure of *At*SPDS1-CHA, where the polyamine groove is occupied by the inhibitor. CHA is bound close to two perpendicularly situated Tyr residues, Tyr106/110 and Tyr270/274, and its amine group crates three hydrogen bonds with acidic residues at the bottom of the polyamine grove ([Figure 3A](#F3){ref-type="fig"}). These are the direct hydrogen bond with Asp208, and the two water-mediated H-bonds with Glu236/240 and Glu50/54. The position of the amine group of CHA overlaps with the PEG molecule that is bound in the apo structures ([Figure 3B](#F3){ref-type="fig"}). The bound PEG molecule stretches along the polyamine groove, resembling PUT bound in other SPDS structures. Therefore, it is highly probable that PUT molecule in *At*SPDS creates a very similar hydrogen bond network to CHA at the bottom of the pocket. The aliphatic portion of PUT is most likely stabilized by the interactions with two perpendicularly positioned aromatic side chains of Tyr106/110 and Tyr270/274 so that the other end of PUT can be pointed close to the cofactor, where it can be deprotonated by Asp201/205 and initialize the transfer of the aminopropyl moiety.

The ligands in the polyamine grove of *At*SPDS do not reach as deep to the bottom of the active site as bound SPD in *Mt*TSPS (PDB ID: 6bq7) ([@B49]). The reason that the amine group of SPD in *Mt*TSPS is placed deeper inside the cleft where it creates a direct hydrogen bond with Glu30 (Glu50/54 of *At*SPDS) is the necessity of *Mt*TSPS to accommodate longer substrate in order to synthesize TSP. This difference in the polyamine binding mode between SPDS and TSPS is caused by several features of the N-terminal β-hairpin that distinguish these two plant APTs and determine their substrate discriminatory features ([@B49]). Additionally, Asp181 of *Mt*TSPS (Asp204/208 in *At*SPDS), the residue which is placed in the loop close to the η6 and in *At*SPDS H-bonds the amine group of the substrate, in *Mt*TSPS is rotated outside the polyamine grove and interacts with Gln214 instead of the substrate. In comparison to plant SPMSs, SPDSs lack the additional insert (about 20 residues) in the N-terminal β-hairpin ([@B49]) which presumably differentiates the shape of the polyamine groove between plant SPDSs and SPMSs, and therefore determines their different specificity.

The binding mode of CHA by *At*SPDS1 is very similar to the binding mode of cyclic and aromatic CHA analogs in *Trypanosoma cruzi* SPDS (PDB ID 4yuw) ([@B2]) and *Plasmodium falciparum* SPDS (*Pf*SPDS, PDB IDs: 4bp3, 4uoe, and 2pt9) ([@B12]; [@B55]). In the case of *Pf*SPDS, the authors observed that the protein requires the stabilization of the flexible region with η6 together with the flanking loops to actually bind the inhibitor ([@B55]). A similar observation was made with *Hs*SPDS where PUT was bound in the active site only when the cofactor was present ([@B60]). In the case of *At*SPDS1 and *At*SPDS2, we have also observed a somewhat similar situation. We have tried to soak the apo *At*SPDS crystals with CHA or to cocrystallize *At*SPDS with CHA alone, but these attempts were unsuccessful. On the other hand, both apo structures, even though there was no ligand in the dc-SAM binding site, presented bound PEG fragment inside the polyamine groove. It is true for all, but one chains of the two apo structures of *At*SPDS. All chains present the conformation very similar to that shown in [Figure 1D](#F1){ref-type="fig"}, which from now on is referred to as a closed state. One subunit of the *At*SPDS2 (chain H) presents the state, where no ligand is bound in the active site in neither the cofactor binding compartment nor in the polyamine groove. The conformation of this chain stands out from the others and presents the possible open conformation of the active site ([Figure 4A](#F4){ref-type="fig"}).

![Structural rearrangements inside the active site of *At*SPDS. **(A)** Superposition of chain A of *At*SPDS1-CHA structure (green) and chain H of *At*SPDS2 (violet), which represents "closed" and "open" conformations of *At*SPDS, respectively; rectangle indicates the region zoomed-in in the bottom panel; red arrows indicate major movements that occur upon ligand binding; note that the view in the bottom panel has been changed by the application of appropriate rotation (bottom left corner). Charge distribution mapped on the surface representation around the active site **(B)** in the closed conformation (chain A of *At*SPDS1) and **(C)** in the open conformation (chain H of *At*SPDS2); dc-SAM (black) and CHA (violet) are superposed from the *At*SPDS1-CHA to indicate the location of the cofactor and the substrate binding sites. Orientation in the panels **(B,C)** is identical to the bottom view of the panel **(A)**. The calculation of the electrostatic potential assuming pH 7.3 was made in *PDB2PQR* and *APBS* ([@B4]; [@B11]).](fpls-10-00555-g004){#F4}

Conformational Movement of *At*SPDS
-----------------------------------

Similarly to the other SPDS enzymes, also *At*SPDS stabilizes upon ligand binding. This feature is even more emphasized when temperature factors of the two very similar (in terms of resolution) structures are compared -- apo *At*SPDS1 and *At*SPDS1-CHA. Apo structure, where no cofactor is bound in the binding site, has an average B factor significantly higher than the complexed structure. Comparison of the chain H of *At*SPDS2 in the open conformation with chain A of the *At*SPDS1-CHA complex ([Figure 4A](#F4){ref-type="fig"}) shows that the *At*SPDS adopts two significantly different conformations. Globally, the main differences between the open (without ligands) and closed (with bound ligands) states concern the following regions ([Figure 4A](#F4){ref-type="fig"}): η6 together with the flanking loops (residues 203/207-214/218), α8 with the preceding loop (residues 235/239-252/256), the loop of the N-terminal β-hairpin (residues 51/55-57/61) and the C-terminus.

In the first-mentioned region, in the closed conformation, the helix η6 is almost perpendicular to the next helix α7 in a way that it entirely covers the cofactor binding site ([Figure 4B](#F4){ref-type="fig"}). Moreover, the loop region is curved in a way that Asp204/208 can reach CHA (or PUT) to create hydrogen bond with its amine group and to stabilize the substrate during the catalysis. In the second region in the closed state, helix α8 is positioned parallelly to the β13 strand of the core β-sheet. The C-terminus is quite well structured and visible in the electron density map up to Ser334/337. Also, the loop of the N-terminal β-hairpin is positioned close to the active site.

In the open conformation, the biggest conformational difference concerns the region with η6. The preceding loop uncoils and η6 is now moved toward α8, over 10 Å away from the position in the closed form. Therefore, the negatively charged active site is uncovered and ready to incorporate cofactor and substrate ([Figure 4C](#F4){ref-type="fig"}). This opening of the active site is possible due to the concerted movement of the other parts of the protein as well. The beginning of α8 helix is shifted almost 6 Å away in comparison to the closed conformation. This shift has an impact not only on the conformation of the preceding loop but also on the C-terminal helix α11, which is also shifted, and it becomes more disordered. Also, the loop of the N-terminal β-hairpin slightly moves outside the pocket ([Figure 4A](#F4){ref-type="fig"}) in the open state, which has a serious consequence for the substrate/inhibitor binding (see below). It is worth noting that the opened conformation of the chain H of *At*SPDS2 was possible to capture only due to the crystal packing, where the residues created additional H-bonds with a symmetry-related unit in the crystal lattice.

The major transition between open and closed state of *At*SPDS around the cofactor binding site ([Figure 5A](#F5){ref-type="fig"}) involves Leu212/216 and Pro208/212, residues from the η6 region that are crucial for the dc-SAM stabilization. Additionally, residues in the glycine-rich region change their position to facilitate dc-SAM. Gly129/133 and Gly130/134 alter their conformation, which in consequence moves the Asp131/135 that is now poised to form a hydrogen bond with the amine group of dc-SAM. Simultaneously, the side chain of Gln107/111 rotates to complement the hydrogen-bonding network with dc-SAM.

![Structural changes of *At*SPDS upon ligand binding. The detailed conformational differences between the closed (chain A of *At*SPDS1-CHA structure, green) and open (chain H of *At*SPDS2 structure, violet) conformations around the cofactor binding site **(A)** and the polyamine groove **(B)**; red arrows indicate major movements; note that the bound dc-SAM (black) and CHA (pink) are bound only in the chain A of *At*SPDS1-CHA; residues are numbered accordingly to the sequence positions of *At*SPDS1 and *At*SPDS2, respectively.](fpls-10-00555-g005){#F5}

Most likely, when the η6 is positioned in the closed conformation after the dc-SAM incorporation, the polyamine grove is adapted for substrate/inhibitor binding. Asp204/208 is rotated to form a hydrogen bond with an amine group of bound ligand inside the polyamine grove ([Figure 5B](#F5){ref-type="fig"}). Also, together with the movement of α8, Glu236/240 is moved inside the active site. The movement of α8 probably has also the impact on the conformation of Trp55/59, which is pushed inside the cleft to shape the bottom wall of the polyamine grove. Also, when the ligand is bound, the side chain of Glu50/54 rotates to form a water-mediated H-bond with the ligand in the polyamine grove.

The fact that SPDS enzymes require the cofactor to be bound first in the dc-SAM binding site can be explained by the necessity of the gate region with η6 to be stabilized in the closed conformation. This helps to preserve the position of Asp204/208 and Glu236/240 in a way that they can easily create H-bonds with bound substrate or inhibitor. Most likely, in the absence of dc-SAM inside the active site the gate region is too unstable, therefore the ligand inside the polyamine grove cannot be sufficiently stabilized. The search across the PDB shows that the region with η6 in most of the APTs is disordered without the ligand bound inside the dc-SAM binding site. *E. coli* SPDS (PDB ID 3o4f) ([@B61]) is another example, where some chains were captured in open conformation, similarly to chain H of *At*SPDS2. On the other hand, such high instability of the η6 without ligands was not observed in *Mt*TSPS ([@B49]). Probably, *Mt*TSPS presents a different mechanism to open the catalytic cleft, where the active site may be opened through a relative movement of C-terminal domains with respect to the N-terminal intersubunit β-barrel.

Conclusion
==========

In this work, we have presented the crystal structures of two isoforms of SPDS from *A. thaliana*, *At*SPDS1 and *At*SPDS2, and compared the unbound and the bound conformations of these enzymes. The structures show the binding mode of dc-SAM, a universal cofactor of APTs and the donor of the aminopropyl moiety. The *At*SPDS1-CHA structure gave insights into the inhibition of the plant SPDSs by CHA. This competitive inhibitor binds inside the polyamine groove of the active site creating three hydrogen bonds at the bottom of the pocket, analogical to these created by the bound substrate. Inside the polyamine grove, the inhibitor is also stabilized by the hydrophobic interactions with two perpendicularly situated Tyr residues, which also stabilize PUT. The crystallographic snapshots show in detail the structural rearrangements around the active site of *At*SPDS that are required to facilitate both, the cofactor and the substrate/inhibitor. The protein undergoes concerted movement of the three major parts (i) close to the glycine-rich region where aminopropyl moiety of dc-SAM is bound, (ii) the very flexible gate region with η6, where residues interact with the adenine moiety of dc-SAM and the bound polyamine/inhibitor, and (iii) the N-terminal β-hairpin, that limits the PUT binding grove at the bottom.
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APT

:   aminopropyltransferase

CHA

:   cyclohexylamine

dc-SAM

:   decarboxylated S-adenosylmethionine

PUT

:   putrescine

SPD

:   spermidine

SPDS

:   spermidine synthase

SPMS

:   spermine synthase

TSPS

:   thermospermine synthase
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